Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boehringer Ingelheim has reported new study results which suggest that its drug Flomax, which treats symptoms of an enlarged prostate, produces significantly greater improvement in patient symptoms than terazosin hydrochloride.
Subscribe to our email newsletter
“Unlike terazosin, tamsulosin (Flomax) does not have to be titrated and patients receive a therapeutically effective dose on day one,” commented Dr Perinchery Narayan, director of the North Florida Urology Association and principal author of the study.
“This study shows that tamsulosin works faster than terazosin in treating the symptoms associated with an enlarged prostate,” added Dr Narayan.
In the study, funded by Boehringer Ingelheim, 1,993 patients with enlarged prostates were randomized to receive tamsulosin or terazosin. Patients taking tamsulosin experienced a statistically and clinically significant improvement (25.3%) in symptoms after four days of treatment, which was not seen in patients who received terazosin (n=884, improvement: 18.1%).